The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis
Open accessAbstract
The human oncoprotein MDM2 (hMDM2) overexpresses in various human tumors. If amplified, the mdm2 gene can enhance the tumorigenic potential of murine cells. Here, we present evidence to show that the full-length human or mouse MDM2 expressed from their respective cDNA can inhibit the G0/G1-S phase transition of NIH 3T3 and normal human diploid cells. The protein harbors more than one cell-cycle-inhibitory domain that does not overlap with the p53-interaction domain. Deletion mutants of hMDM2 that lack the cell-cycle-inhibitory domains can be stably expressed in NIH 3T3 cells, enhancing their tumorigenic potential. The tumorigenic domain of hMDM2 overlaps with the p53-interaction domain. Some tumor-derived cells, such as Saos-2, H1299 or U-2OS, are relatively insensitive to the growth-inhibitory effects of hMDM2. These observations suggest that hMDM2 overexpression in response to oncogenic stimuli would induce growth arrest in normal cells. Elimination or inactivation of the hMDM2-induced G0/G1 arrest may contribute to one of the steps of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Small increases in Mdm2 levels in normal cells are tolerated”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Brown, et al., 1998
In the citing paper
“higher levels are incompatible with life in vivo and in vitro, except in some cases when p53 is also inactivated”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Brown, et al., 1998
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“A recent report (Serrano et al., 1997) has demonstrated that overexpression of oncogenic ras can induce G1 arrest of primary human and rodent cells.”
BackgroundCurrent Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,574
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,629
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 3×
“The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis”
Backgroundmdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 3×
“The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis”
BackgroundMonoclonal antibodies specific for simian virus 40 tumor antigens
Harlow, E., Crawford, L. V., Pim, D. C., & Williamson, N. M. (1981) · Journal of Virology · doi:10.1128/jvi.39.3.861-869.1981 · Cited by 1,038
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
p53 Functions as a Cell Cycle Control Protein in Osteosarcomas
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M. C., Bressac, B., Öztürk, M., Baker, S. J., Vogelstein, B., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 775
Hunter, T. R. (1991) · Cell · doi:10.1016/0092-8674(91)90637-e · Cited by 758
Fakharzadeh, S. S., Trusko, S. P., & George, D. L. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07676.x · Cited by 704
Mapping of the p53 and mdm-2 Interaction Domains
Chen, J., Maréchal, V., & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 700
Lee, W., Shew, J., Hong, F., Sery, T. W., Donoso, L. A., Young, L.-J., Bookstein, R., & Lee, E. Y.-H. P. (1987) · Nature · doi:10.1038/329642a0 · Cited by 628
Interaction between the retinoblastoma protein and the oncoprotein MDM2
Xiao, Z.-X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J. W., Sellers, W. R., & Livingston, D. M. (1995) · Nature · doi:10.1038/375694a0 · Cited by 586
Levine, A. J. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.003203 · Cited by 534
p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach, F. S., Tokino, T., Meltzer, P. S., Burrell, M., Oliner, J., Smith, S., HILL, D. E., Sidransky, D., Kinzler, K. W., & Vogelstein, B. (1993) · PubMed · Cited by 533
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.Preprint
Zhu, L., van den Heuvel, S., Helin, K., Fattaey, A., Ewen, M. E., Livingston, D. M., Dyson, N. J., & Harlow, E. E. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1111 · Cited by 516
(1994) · PubMed · Cited by 509
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H. A., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 473
(1993) · PubMed · Cited by 469
Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
Martin, K., Trouche, D., Hagemeier, C., Sørensen, T. S., Thangue, N. B. L., & Kouzarides, T. (1995) · Nature · doi:10.1038/375691a0 · Cited by 454
Mitsudomi, T., Steinberg, S. M., Nau, M. M., Carbone, D. P., D'Amico, D., Bodner, S. M., Oie, H. K., Linnoila, R. I., Mulshine, J. L., & Minna, J. D. (1992) · Lung Cancer · doi:10.1016/0169-5002(92)90040-q · Cited by 441
Sugden, B., Marsh, K., & Yates, J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.2.410 · Cited by 438
Hinds, P. W., Finlay, C. A., Quartin, R. S., Baker, S. J., Fearon, E. R., Vogelstein, B., & Levine, A. J. (1990) · PubMed · Cited by 408
mdm-2 Inhibits the G1 Arrest and Apoptosis Functions of the p53 Tumor Suppressor Protein
Chen, J., Wu, X., Lin, J., & Levine, A. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2445 · Cited by 348
MDM2 gene amplification in metastatic osteosarcoma.
Ladanyi, M., Cha, C. H., Lewis, R., Jhanwar, S. C., Huvos, A. G., & Healey, J. H. (1993) · PubMed · Cited by 342
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Khatib, Z. A., Matsushime, H., Valentine, M. B., Shapiro, D. N., Sherr, C. J., & Look, A. T. (1993) · PubMed · Cited by 339
Juven‐Gershon, T., Barak, Y., Zauberman, A., George, D. L., & Oren, M. (1993) · PubMed · Cited by 332
Barak, Y., Gottlieb, E., Juven-Gershon, T., & Oren, M. (1994) · Genes & Development · doi:10.1101/gad.8.15.1739 · Cited by 328
The Ribosomal L5 Protein Is Associated with mdm-2 and mdm-2-p53 Complexes
Maréchal, V., Elenbaas, B., Piette, J., Nicolas, J. C., & Levine, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7414 · Cited by 318
Mittnacht, S., & Weinberg, R. A. (1991) · Cell · doi:10.1016/0092-8674(91)90456-9 · Cited by 311
The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
Finlay, C. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.301 · Cited by 311
Reifenberger, G., REIFENBERGER, J., Ichimura, K., Meltzer, P. S., & Collins, V. P. (1994) · PubMed · Cited by 279
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
Chen, C. Y., Oliner, J., Zhan, Q., Fornace, A. J., Vogelstein, B., & Kastan, M. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2684 · Cited by 270
Sigalas, I., Calvert, A. H., Anderson, J. J., Neal, D. E., & Lunec, J. (1996) · Nature Medicine · doi:10.1038/nm0896-912 · Cited by 268
The mdm-2 gene is induced in response to UV light in a p53-dependent manner.
Perry, M. E., Piette, J., Zawadzki, J., Harvey, D., & Levine, A. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11623 · Cited by 247
Lundgren, K., Montes de Oca Luna, R., McNeill, Y. B., Emerick, E. P., Spencer, B., Barfield, C. R., Lozano, G., Rosenberg, M. P., & Finlay, C. A. (1997) · Genes & Development · doi:10.1101/gad.11.6.714 · Cited by 235
Cell type‐specific inhibition of p53‐mediated apoptosis by mdm2.
Haupt, Y., Barak, Y., & Oren, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00504.x · Cited by 228
p53 Functions as a Cell Cycle Control Protein in Osteosarcomas
Diller, L., Kassel, J., Nelson, C. E., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772-5781.1990 · Cited by 228
Picksley, S. M., & Lane, D. P. (1993) · BioEssays · doi:10.1002/bies.950151008 · Cited by 207
Lane, D. P. (1994) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072911 · Cited by 195
Band, V, & Sager, R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1249 · Cited by 194
Sugden, B., Marsh, K., & Yates, J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.2.410-413.1985 · Cited by 189
Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
Olson, D. C., Maréchal, V., Momand, J. A., Chen, J., Romocki, C., & Levine, A. J. (1993) · PubMed · Cited by 188
MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene Status
Flørenes, V. A., Mælandsmo, G. M., Forus, A., Andreassen, Å. K., Myklebost, O., & Fodstad, Ø. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.17.1297 · Cited by 188
Tumor progression in four mammary epithelial cell lines derived from the same patient.
Band, V., Zajchowski, D. A., Swisshelm, K. L., Trask, D. K., Kulesa, V., Cohen, C., Connolly, J. L., & Sager, R. (1990) · PubMed · Cited by 176
Inhibition of viral and cellular promoters by human wild-type p53
Subler, M. A., Martin, D. W., & Deb, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4757-4762.1992 · Cited by 171
C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
Shew, J., Lin, B. T., Chen, P., Tseng, B., Yang‐Feng, T. L., & Lee, W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.6 · Cited by 164
Nuclear location signal-mediated protein transport
Roberts, B. (1989) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(89)90016-x · Cited by 140
Physical and Functional Interaction between Wild-Type p53 and mdm2 Proteins
Haines, D. S., Landers, J. E., Engle, L. J., & George, D. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1171 · Cited by 136
The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.
Sheikh, M. S., Shao, Z. M., Hussain, A., & Fontana, J. A. (1993) · PubMed · Cited by 127
Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter
Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120
Self-citationPollice, A. A., McCoy, J. P., Shackney, S. E., Smith, C. A., Agarwal, J., Burnolt, D. R., Janocko, L. E., Hornicek, F. J., Singh, S. G., & Hartsock, R. J. (1992) · Cytometry · doi:10.1002/cyto.990130414 · Cited by 111
The Ribosomal L5 Protein Is Associated with mdm-2 and mdm-2-p53 Complexes
Maréchal, V., Elenbaas, B., Piette, J. G., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7414-7420.1994 · Cited by 107
Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.
Linardopoulos, S., Street, A. J., Quelle, D. E., Parry, D., Peters, G. G., Sherr, C. J., & Balmain, A. (1995) · PubMed · Cited by 105
Gudas, J. M., Nguyen, H., Klein, R. C., Katayose, D., Seth, P. K., & Cowan, K. H. (1995) · PubMed · Cited by 74
DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells.
Price, B. D., & Park, S. J. (1994) · PubMed · Cited by 73
Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle, D. E., Ashmun, R. A., Hannon, G. J., Rehberger, P. A., Trono, D., Richter, K. H., Walker, C., Beach, D., Sherr, C. J., & Serrano, M. (1995) · PubMed · Cited by 69
MDM2 gene amplification in human breast cancer
Quesnel, B., Preudhomme, C., Fournier, J., Fenaux, P., & Peyrat, J. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90128-7 · Cited by 67
Amplification of a gene encoding a p53-associated protein in human sarcomas
(1992) · Trends in Genetics · doi:10.1016/0168-9525(92)90271-5 · Cited by 64
Brown, D. R., Deb, S., Muñoz, R. M., Subler, M. A., & Deb, S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.6849 · Cited by 58
Self-citationCell Cycle — Materials and Methods
Pagano, M. (1996) · Springer eBooks · doi:10.1007/978-3-642-57783-3 · Cited by 52
Leng, R. P., Brown, D. R., Shivakumar, C., Deb, S., & Deb, S. (1995) · PubMed · Cited by 48
Self-citationLevine, A. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.62.1.623 · Cited by 47
Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53.
Otto, A., & Deppert, W. (1993) · PubMed · Cited by 41
Analysis of Flow Cytometry Data
Sharrow, S. O. (1991) · Current Protocols in Immunology · doi:10.1002/0471142735.im0502s00 · Cited by 30
Induction of p53-, MDM2-, and WAF1/CIP1-like Molecules in Insect Cells by DNA-Damaging Agents
Bae, I., Smith, M. L., & Fornace, A. J. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1120 · Cited by 25
MDM2 overexpression in benign and malignant lesions of the human breast
Baunoch, D., Watkins, L. F., Tewari, A., Reece, M. T., Adams, L. M., Stack, R., Brown, A., Jones, L. A., Christian, D., Latif, N. A., et al. (1996) · International Journal of Oncology · doi:10.3892/ijo.8.5.895 · Cited by 22
Brown, D. R., Deb, S., Muñoz, R. M., et al. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.6849-6857.1993 · Cited by 22
Self-citationHUMAN ONCOPROTEIN MDM2 INTERACTS WITH THE TATA-BINDING PROTEIN IN-VITRO AND IN-VIVO
Leng, R. P., Brown, D. R., Deb, S. P., & Deb, S. P. (1995) · International Journal of Oncology · doi:10.3892/ijo.6.1.251 · Cited by 19
Self-citationSelective compartmentalization of different mdm2 proteins within the nucleus.
Maxwell, S. A. (1995) · PubMed · Cited by 13
TRANSCRIPTIONAL ANTAGONISM BETWEEN P53 AND SV40 T-ANTIGEN
Deb, S., Brown, D. R., LEGA, H., & Deb, S. P. (1995) · International Journal of Oncology · doi:10.3892/ijo.6.1.243 · Cited by 3
Self-citationWang (1997) · doi:10.1002/(sici)1096-9896(199705)182:1
Cited by
Sorted by citations
Ashcroft, M. A., & Vousden, K. H. (1999) · Oncogene · doi:10.1038/sj.onc.1203012 · Cited by 411
The Mdm2–p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
Manfredi, J. J. (2010) · Genes & Development · doi:10.1101/gad.1941710 · Cited by 344
Alternative and aberrant splicing of MDM2 mRNA in human cancer
Bartel, F., Taubert, H. W., & Harris, L. C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00091-0 · Cited by 196
Juven‐Gershon, T., & Oren, M. (1999) · Molecular Medicine · doi:10.1007/bf03402141 · Cited by 193
Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression
Scian, M. J., Stagliano, K. E., Anderson, M. A. E., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., & Deb, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10097-10110.2005 · Cited by 152
Metadata
- Authors
- Brown, D. R., Thomas, C. A., & Palit Deb, S.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- ORCID
- Brown, Doris R.
- Venue
- The EMBO Journal
- Published
- 1998-05-01
- Volume
- 17
- Issue
- 9
- Pages
- 2513-2525
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1170593
- OpenAlex
- W2014749419
- Cited by
- 148
- References
- 78
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 6 · 2013: 4 · 2012: 14
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA070712, CA70712)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- MDM2, oncoprotein, cell cycle arrest, G0/G1 arrest, carcinogenesis, deletion mutants, NIH3T3 cells, cancer cell lines, oncogene overexpression, growth inhibition
- MeSH terms
- Animals, Cell Cycle, Cell Division, Cell Line, Cell Transformation, Neoplastic, Flow Cytometry, Gene Amplification, Humans, Neoplasm Proteins, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Proteins, Transfection, Resting Phase, Cell Cycle, G1 Phase, S Phase, Mutagenesis, Site-Directed, 3T3 Cells, Sequence Deletion, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
